Literature DB >> 28540445

Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.

Alanoud Alshami1, Abishek Roshan1, Marisa Catapang1, Jasper J Jöbsis1, Trevor Kwok1, Nonnie Polderman1, Jennifer Sibley1, Matt Sibley1, Cherry Mammen1, Douglas G Matsell2,3.   

Abstract

BACKGROUND: Most cases of childhood nephrotic syndrome (NS) are due to minimal change disease (MCD), while a minority of children have focal segmental glomerulosclerosis (FSGS) and an unfavorable clinical course, requiring a kidney biopsy to confirm diagnosis. We hypothesized that clinical characteristics at diagnosis and initial response to corticosteroid treatment accurately predict FSGS and can be used to guide consistent practice in the indications for kidney biopsy.
METHODS: This was a case control study (1990-2012). Inclusion criteria included age 1-17 years, meeting the diagnostic criteria for NS, and having biopsy-proven FSGS or MCD. Clinical characteristics at diagnosis included age, kidney function [estimated glomerular filtration rate (eGFR)], hypertension, hematuria, nephritis (reduced eGFR, hematuria, hypertension), and response to steroids.
RESULTS: From a total of 169 children who underwent kidney biopsy for NS we included 65 children with MCD and 22 with FSGS for analysis. There were no significant between-group differences in age, sex, or eGFR at the time of diagnosis. The FSGS group had a higher proportion of hypertension (40 vs. 15%; p = 0.02), hematuria (80 vs. 47%; p = 0.01), and nephritis (22 vs. 2%; p = 0.004) and was more likely to be steroid resistant after 6 weeks of treatment than the MCD group (67 vs. 19%; p < 0.001). As predictors of FSGS, hematuria had a high sensitivity of 0.80 [95% confidence interval (CI) 0.56-0.93] and low specificity of 0.53 (95% CI 0.39-0.66), nephritis had a low sensitivity of 0.22 (95% CI 0.07-0.48) and high specificity of 0.98 (95% CI 0.88-0.99), and steroid resistance had a low sensitivity of 0.67 (95% CI 0.43-0.85) and high specificity of 0.81 (95% CI 0.68-0.90). The combination of steroid resistance after 6 weeks of therapy and/or nephritis at diagnosis yielded the optimal sensitivity and specificity at 0.80 (95% CI 0.56-0.93) and 0.75 (95% CI 0.60-0.86), respectively, confirmed by the highest receiver operator characteristic area under the curve of 0.77.
CONCLUSION: Steroid resistance after 6 weeks of therapy and/or nephritis at initial presentation is an accurate predictor of FSGS in children with NS and will be used as the indication for kidney biopsy in our newly developed clinical pathway. This approach will maximize the yield of diagnostic FSGS biopsies while minimizing the number of unnecessary MCD biopsies.

Entities:  

Keywords:  Biopsy; Childhood; Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome

Mesh:

Substances:

Year:  2017        PMID: 28540445     DOI: 10.1007/s00467-017-3687-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  33 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children.

Authors:  M Bonilla-Felix; C Parra; T Dajani; M Ferris; R D Swinford; R J Portman; R Verani
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

3.  Primary focal segmental glomerulosclerosis in children: prognostic factors.

Authors:  R Martinelli; A S Okumura; L J Pereira; H Rocha
Journal:  Pediatr Nephrol       Date:  2001-08       Impact factor: 3.714

4.  Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

5.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

6.  Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis.

Authors:  Douglas M Silverstein; Randall Craver
Journal:  Clin J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 8.237

7.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

8.  Focal segmental glomerulosclerosis with and without nephrotic syndrome in children.

Authors:  N Yoshikawa; H Ito; R Akamatsu; S Matsuyama; O Hasegawa; C Nakahara; T Matsuo
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

Review 9.  Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature.

Authors:  Loubna El Bakkali; Robert Rodrigues Pereira; Dirk J Kuik; Johannes C F Ket; Joanna A E van Wijk
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

Review 10.  Ethnic Differences in Childhood Nephrotic Syndrome.

Authors:  Rahul Chanchlani; Rulan S Parekh
Journal:  Front Pediatr       Date:  2016-04-19       Impact factor: 3.418

View more
  4 in total

1.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

2.  Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.

Authors:  Lívia Helena de Morais Pereira; Crislaine Aparecida da Silva; Maria Luíza Gonçalves Dos Reis Monteiro; Liliane Silvano Araújo; Laura Penna Rocha; Marcelo Bernardes da Rocha Reis; Fernando Silva Ramalho; Rosana Rosa Miranda Corrêa; Marcos Vinicius Silva; Marlene Antonia Reis; Juliana Reis Machado
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

Review 3.  Management of Steroid-Resistant Nephrotic Syndrome in Children.

Authors:  Sanjana Sachdeva; Syeda Khan; Cristian Davalos; Chaithanya Avanthika; Sharan Jhaveri; Athira Babu; Daniel Patterson; Abdullah J Yamani
Journal:  Cureus       Date:  2021-11-08

Review 4.  Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review.

Authors:  Henry H L Wu; Mohan Shenoy; Philip A Kalra; Rajkumar Chinnadurai
Journal:  Children (Basel)       Date:  2021-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.